Compare Illumina, Inc. (ILMN) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Western Alliance Bancorporation — how do they compare? Illumina, Inc. trades at $278 (market cap $39.95B), while Western Alliance Bancorporation trades at $74.18 (market cap $8.24B). The key difference: Illumina, Inc. is far larger — about 4.8× Western Alliance Bancorporation's market cap, and Western Alliance Bancorporation pays a 2.23% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Western Alliance Bancorporation for 3 Days on average.
| ILMN | WAL | |
|---|---|---|
Market Cap | $39.95B | $8.24B |
Volume | 3,169,503 | 1,387,161 |
Sector | Health | Financials |
52-Week High | $293.69 | $96.08 |
52-Week Low | $91.00 | $66.70 |
Typical Hold Time | 83 Days | 3 Days |
Enterprise Value | $41.31B | $9.76B |
Dividend Yield | — | 2.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $271.02, up 1.22% and near its 52-week high, reflecting strong momentum. The stock exhibits a bullish technical trend with recent earnings beats and a positive analyst consensus. Revenue for 2025 was $4.34B with net income of $850M, marking a significant profit margin recovery. Cash flow from operations remains robust at $1.08B, supporting financial stability. Inclusion in the S&P 500 and focus on AI-driven genomics growth are key catalysts.
Outlook is positive given earnings momentum and strategic initiatives, but risks include valuation premiums and competitive pressures. The stock offers growth exposure to genomic innovation, though investors should monitor execution on AI integration and margin sustainability. Analyst price targets suggest moderate upside from current levels, with consensus at $241.00.
Western Alliance Bancorporation (WAL) trades at $74.41, showing minimal daily movement with a 0.08% gain. The stock presents compelling valuation metrics with a P/E of 8.52 and P/B of 1.09, while maintaining strong profitability with 25.43% net income margin. Recent Q2 2026 earnings matched expectations at $2.36 EPS, though technical indicators signal bearish momentum with resistance at $76-78 levels. The company continues to expand its digital banking platform with the recent WA VenueX launch.
WAL offers value investment potential with analyst consensus price target of $84.33 representing 13% upside. Strong institutional accumulation and 79% buy ratings support the bullish case, though bearish technical signals and potential regulatory changes for banks present near-term headwinds. The improving cash flow trend from -$500M to +$3.2B net cash flow in 2026 indicates strengthening financial position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
